Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.

X

Navigate / search

Silencing of HIV-1 Proviruses (R61/R33)

Key Dates: 
  • Posted Date: May 17, 2017
  • Open Date (Earliest Submission Date): November 6, 2017
  • Letter of Intent Due Date(s): November 6, 2017 Application Due Date(s) December 6, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • AIDS Application Due Date(s): December 6, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Scientific Merit Review: April 2018
  • Advisory Council Review: May 2018
  • Earliest Start Date: July 2018
Purpose: 

This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses

Expiration Date: 
Thursday, December 7, 2017
Announcement Number: 
RFA-AI-17-013